EVALUATION OF THE SYSTEMIC AND REGIONAL ANTIBIOTIC THERAPY EFFECTIVENESS AS PART OF COMPLEX THERAPY IN PATIENTS WITH LOCALLY SPREAD BREAST CANCER

Oleksandr Bondar

Abstract


In recent years, breast cancer is the most common oncologic pathology and the most common cause of disability among women in developed countries.

The aim of the study. To improve direct and long-term results of treatment in patients with locally spread forms of breast cancer (LSBC) by accelerated regression of perifocal inflammatory changes using selective intraarterial application of antibiotics; improving patients’ quality of life.

Materials and methods. The main sample consisted of 109 patients.The control group included 65 (61 %) clinical cases of LSBC who were performed series of courses of intravenous systemic polychemotherapy (SPHT) as neoadjuvant therapy accompanied by systemic intravenous antibiotic therapy. The study group consisted of 42 (39 %) patients who were performed selective intraarterial neoadjuvant polychemotherapy course with simultaneous regional use of antibiotic therapy in the intraarterial administration.

Results. The regional administration of antibiotics as a part of the complex neoadjuvant therapy, along with the method of selective intraarterial polychemotherapy, has a positive effect on the linear and chronometric regression of perifocal inflammatory changes around the focus of the primary inoperable LSBC, which positively affects the somatic and psychological patient's state and increases the quality of his life.

Conclusions. The complex regional impact on the affected organ has a statistically confirmed better effect with bright holistic features, demonstrating the additive synergism of selective techniques.The selective intraarterial antibiotic therapy does not require additional time and material costs while increasing the efficiency of the method. The versatile advanced approach positively affects the somatic and psychological state of the patient. 


Keywords


locally spread breast cancer; complex treatment; intraarterial polychemotherapy; antibiotic therapy; quality of life

Full Text:

PDF

References


Yamauchi, H., Woodward, W. A., Valero, V., Alvarez, R. H., Lucci, A., Buchholz, T. A. et. al. (2012). Inflammatory Breast Cancer: What We Know and What We Need to Learn. The Oncologist, 17 (7), 891–899. doi: http://doi.org/10.1634/theoncologist.2012-0039

Wirtz, H. S., Buist, D. S. M., Gralow, J. R., Barlow, W. E., Gray, S., Chubak, J. et. al. (2013). Frequent Antibiotic Use and Second Breast Cancer Events. Cancer Epidemiology Biomarkers & Prevention, 22 (9), 1588–1599. doi: http://doi.org/10.1158/1055-9965.epi-13-0454

Ording, A. G., Garne, J. P., Nyström, P. M. W., Cronin-Fenton, D., Tarp, M., Sørensen, H. T., Lash, T. L. (2012). Hospital Recorded Morbidity and Breast Cancer Incidence: A Nationwide Population-Based Case-Control Study. PLoS ONE, 7 (10), e47329. doi: http://doi.org/10.1371/journal.pone.0047329

Landercasper, J., Bailey, L., Buras, R., Clifford, E., Degnim, A. C., Thanasoulis, L. et. al. (2017). The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters. Annals of Surgical Oncology, 24 (10), 3093–3106. doi: http://doi.org/10.1245/s10434-017-5940-1

Greenlee, H., DuPont-Reyes, M. J., Balneaves, L. G., Carlson, L. E., Cohen, M. R., Deng, G. et. al. (2017). Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians, 67 (3), 194–232. doi: http://doi.org/10.3322/caac.21397

Picon-Ruiz, M., Morata-Tarifa, C., Valle-Goffin, J. J., Friedman, E. R., Slingerland, J. M. (2017). Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA: A Cancer Journal for Clinicians, 6 7(5), 378–397. doi: http://doi.org/10.3322/caac.21405

Akram, M., Iqbal, M., Daniyal, M., Khan, A. U. (2017). Awareness and current knowledge of breast cancer. Biological Research, 50 (1). doi: http://doi.org/10.1186/s40659-017-0140-9

NCCN guidelines for patients: caring for adolescents and young adults. (2013). Fort Washington: National Comprehensive Cancer Network.

Fayers, P., Aaronson, N., Bjordal, K. et. al. (2001). EORTC QLQ-C30 scoring manual. Brussels: EORTC Publications.

Canto, J. G., Kiefe, C. I. (2014). Age-Specific Analyses of Breast Cancer Versus Heart Disease Mortality in Women. The American Journal of Cardiology, 113 (2), 410–411. doi: http://doi.org/10.1016/j.amjcard.2013.08.055

Howard-Anderson, J., Ganz, P. A., Bower, J. E., Stanton, A. L. (2012). Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic Review. JNCI Journal of the National Cancer Institute, 104 (5), 386–405. doi: http://doi.org/10.1093/jnci/djr541

DeSantis, C., Ma, J., Bryan, L., Jemal, A. (2013). Breast cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 64 (1), 52–62. doi: http://doi.org/10.3322/caac.21203

Liu, L., Fiorentino, L., Rissling, M., Natarajan, L., Parker, B. A., Dimsdale, J. E. et. al. (2013). Decreased Health-Related Quality of Life in Women With Breast Cancer Is Associated With Poor Sleep. Behavioral Sleep Medicine, 11 (3), 189–206. doi: http://doi.org/10.1080/15402002.2012.660589

Sharma, N., Purkayastha, A. (2017). Factors affecting quality of life in breast cancer patients: A descriptive and cross-sectional study with review of literature. Journal of Mid-Life Health, 8 (2), 75–83. doi: http://doi.org/10.4103/jmh.jmh_15_17

Eom, C.-S., Shin, D. W., Kim, S. Y., Yang, H. K., Jo, H. S., Kweon, S. S. et. al. (2012). Impact of perceived social support on the mental health and health-related quality of life in cancer patients: results from a nationwide, multicenter survey in South Korea. Psycho-Oncology, 22 (6), 1283–1290. doi: http://doi.org/10.1002/pon.3133

Gray, J. M., Rasanayagam, S., Engel, C., Rizzo, J. (2017). State of the evidence 2017: an update on the connection between breast cancer and the environment. Environmental Health, 16 (1). doi: http://doi.org/10.1186/s12940-017-0287-4

Anampa, J., Makower, D., Sparano, J. A. (2015). Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Medicine, 13 (1). doi: http://doi.org/10.1186/s12916-015-0439-8

Masood, S. (2016). Neoadjuvant chemotherapy in breast cancers. Women’s Health, 12 (5), 480–491. doi: http://doi.org/10.1177/1745505716677139

Teshome, M., Hunt, K. K. (2014). Neoadjuvant Therapy in the Treatment of Breast Cancer. Surgical Oncology Clinics of North America, 23 (3), 505–523. doi: http://doi.org/10.1016/j.soc.2014.03.006




DOI: http://dx.doi.org/10.21303/2504-5679.2019.00882

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Oleksandr Bondar

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)